Difference between revisions of "Aldesleukin (Proleukin)"
Jump to navigation
Jump to search
(delete regimens section) |
|||
| Line 9: | Line 9: | ||
*[http://chemocare.com/bio/aldesleukin.asp Aldesleukin (Proleukin) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/aldesleukin.asp Aldesleukin (Proleukin) patient drug information (Chemocare)]</ref> | *[http://chemocare.com/bio/aldesleukin.asp Aldesleukin (Proleukin) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/aldesleukin.asp Aldesleukin (Proleukin) patient drug information (Chemocare)]</ref> | ||
*[http://www.uptodate.com/contents/aldesleukin-patient-drug-information Aldesleukin (Proleukin) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/aldesleukin-patient-drug-information Aldesleukin (Proleukin) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/aldesleukin-patient-drug-information Aldesleukin (Proleukin) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/aldesleukin-patient-drug-information Aldesleukin (Proleukin) patient drug information (UpToDate)]</ref> | ||
| − | |||
| − | |||
| − | |||
| − | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 02:45, 24 December 2011
General information
Class/mechanism: Recombinant IL-2, immune system activation.[1][2]
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert[1].
Patient drug information
- Aldesleukin (Proleukin) patient drug information (Chemocare)[3]
- Aldesleukin (Proleukin) patient drug information (UpToDate)[4]